🔎 Trials Near Me

Utama › Glioma › Pennsylvania

Kajian klinikal Glioma di Pennsylvania

19 kajian untuk Glioma sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Geisinger Medical Center, Danville
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • dan 1 lagi
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Mengambil pesertaFasa 1/2
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04094610

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

  • The Children s Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa awal 1
Umur 1 hingga 21 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05555550

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Children's Hospital of Philidelphia, Philidelphia
Mengambil pesertaFasa 2
12 Months – 39 Years · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaKajian pemerhatian
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Thomas Jefferson University Hospital, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Thomas Jefferson University, Philadelphia
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

  • Lehigh Valley Health Network (Data Collection Only), Allentown
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05188508

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 1/2
Umur 4 hingga 39 · Semua jantina · Dikemas kini 20 Jul 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
Umur 1 hingga 21 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
12 Months – 39 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • UPMC Hillman Cancer Center, Pittsburgh
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06326411

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa awal 1
Sehingga umur 21 · Semua jantina · Dikemas kini 18 Mac 2026 · NCT04655404

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

  • University of Pennsylvania, Philadelphia
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Feb 2026 · NCT05345002

18F-Fluciclovine PET-MRI in High-grade Glioma

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa awal 1
Umur 1 hingga 21 · Semua jantina · Dikemas kini 4 Dis 2025 · NCT05553041

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.